The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Casapinos I think that you are right and I am in for the long haul, I will take up my rights but these may take a tumble and PI's may get in lower than me, but Ha Ho it is going to be a tough year and I know fa
I've been in GKP for years, and realise that these people that run these companies and a lot of AIM companies do so with only themselves in mind, they are not interested in private investors
therefore only invest what you can afford to loose, if you do make a profit always take it, or part of it and move on
gla
Gareth I take comfort from your posting, 30p would be great. I do recall in Nov. 2019 when the price went to around 30p that I had sold at 21p thinking that I had done ok, just to see it rise further , so bought back in at 28p. It just fell and fell I think I sold at around 16p. I just don't learn, when in profit on AIM sell and count your blessings, but I bet that I will try again
gla
All pharma shares are volatile, immupharma moves for no apparent reason I see GSK as similar, you think that you have a profit just to see it fall back. IMM will fall back and that is the time to get in
Most of the AIM market tactic is to take the profit when it shows. It prevents you from losing your shirt
Good Luck Guys